Evotec - Research never stops
  • Loading...

Archive



Dec 06, 2005

Evotec Reaches First Milestone and Receives Success Payment in Alzheimer's Disease Collaboration with Takeda

- read more
Nov 29, 2005

3i has reduced its interest in Evotec to 4.1%

- read more
Nov 14, 2005

Evotec Announces Initiation of Phase I Clinic Trial with EVT 101

- read more
Nov 09, 2005

Third Quarter 2005: Third consecutive quarter of strong services performance and first compound in Phase I clinical trials

- read more
Nov 03, 2005

Boehringer Ingelheim Extends Scope of Collaboration with Evotec into Screening Services - New agreements signed with Boehringer Ingelheim Germany and Canada

- read more
Oct 20, 2005

Evotec Reports Positive Results of Repositioning Clinical Trial on CNS Compound

- read more
Sep 08, 2005

ProPharma Integrated into Evotec Services Division

- read more
Aug 11, 2005

Second Quarter 2005: Evotec Progressing as Planned

- read more
Jul 25, 2005

Procter & Gamble Selects Evotec as Provider of Pharmaceutical Discovery and Chemical Development Services

- read more
Jul 21, 2005

Evotec Enters into Long-Term Focused Library Agreement with Almirall - Value Exceeding EUR 2.5 m over the Two-Year Contract Period

- read more
Jul 05, 2005

Evotec Names Dr Tim Tasker Executive Vice President Clinical Development and Member of the Executive Committee

- read more
Jun 24, 2005

Evotec Raised EUR 28.4 Million in Capital Increase

- read more
Jun 07, 2005

Evotec OAI Announces AGM Approval of Capital Increase and New Supervisory Board Structure

- read more
Jun 07, 2005

Evotec OAI Achieves First Milestone in Partnership with Boehringer Ingelheim

- read more
May 10, 2005

First Quarter 2005: Full-Year Guidance Confirmed Following Strong Q1 2005

- read more
May 06, 2005

Evotec OAI Proposes Changes to its Supervisory Board to Support the Implementation of its Strategy of Proprietary Drug Development

- read more
Apr 13, 2005

Evotec OAI Extends Global Medicinal Chemistry Agreement with Roche

- read more
Mar 22, 2005

Evotec OAI AG Report Financial Results 2004 and Guidance for 2005: Strong Q4 and Solid Outlook

- read more
Mar 06, 2005

Evotec Acquires ENS and Secures €47m in Cash to Develop CNS Pipeline

- read more
Feb 16, 2005

Evotec OAI to Provide Process Validation for AnorMED Inc. Phase III Compound, AMD 3100

- read more
Feb 03, 2005

Evotec OAI's Preliminary Results 2004: Strong Q4 Performance

- read more
Jan 19, 2005

Evotec OAI Appoints Mary Tanner to its Supervisory Board: New Board Member brings significant life science and investment banking expertise

- read more